Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency.
Danish Center for Sleep Medicine, University of Copenhagen, Glostrup Hospital, Glostrup, Denmark. stine.knudsen@dadlnet.dk
Stine
S
Knudsen
Bo
B
Biering-Sørensen
Birgitte R
BR
Kornum
Eva R
ER
Petersen
Jette D
JD
Ibsen
Steen
S
Gammeltoft
Emmanuel
E
Mignot
Poul J
PJ
Jennum
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D047908:Intracellular Signaling Peptides and Proteins / Q000172:deficiency* / Q000235:genetics; D008297:Male; D009290:Narcolepsy / Q000188:drug therapy* / Q000235:genetics / Q000821:virology*; D009479:Neuropeptides / Q000172:deficiency* / Q000235:genetics; D000068797:Orexins; D010641:Phenotype; D016896:Treatment Outcome; D055815:Young Adult
D016756:Immunoglobulins, Intravenous; D007252:Influenza Vaccines; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins